BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mendias CL, Enselman ERS, Olszewski AM, Gumucio JP, Edon DL, Konnaris MA, Carpenter JE, Awan TM, Jacobson JA, Gagnier JJ, Barkan AL, Bedi A. The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial. Am J Sports Med 2020;48:1916-28. [PMID: 32452208 DOI: 10.1177/0363546520920591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Biagetti B, Simó R. GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice. Int J Mol Sci 2021;22:E415. [PMID: 33401779 DOI: 10.3390/ijms22010415] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Catapano M, Ahmed M, Breslow RG, Borg-Stein J. The aging athlete. PM R 2022;14:643-51. [PMID: 35441493 DOI: 10.1002/pmrj.12814] [Reference Citation Analysis]
3 Criss CR, Melton MS, Ulloa SA, Simon JE, Clark BC, France CR, Grooms DR. Rupture, reconstruction, and rehabilitation: A multi-disciplinary review of mechanisms for central nervous system adaptations following anterior cruciate ligament injury. Knee 2021;30:78-89. [PMID: 33873089 DOI: 10.1016/j.knee.2021.03.009] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]